Alexion and Moderna have an exclusive strategic agreement for the discovery and development of messenger RNA Therapeutics™ for rare diseases.
Moderna announces a landmark publication describing the first-ever protein production through messenger RNA therapeutics™.
Moderna and AstraZeneca have a strategic option agreement to develop up to forty messenger RNA Therapeutics™ for the treatment of serious cardiometabolic diseases and cancer.
We are delivering the next wave of innovation to treat serious illness.
We’ve assembled a team of scientists and drug hunters, executives and visionaries. Our experience is matched only by our passion.
watch our video
July 1, 2014
Moderna Appoints Oncology Leader Dr. Stephen Kelsey as President of Onkaido | Read more
June 17, 2014
Moderna Named to CNBC Disruptor 50 List | Read more
June 12, 2014
Moderna Announces Expansion to New Facility in Kendall Square | Read more